3.8 C
New York
Monday, February 6, 2023

Buy now

ZyCoV-D: Another corona vaccine approved, the first needle-free vaccine

Recognition of the sixth corona vaccine in India

Mumbai: Zydus Cadillac corona vaccine has been approved for emergency use in India. The vaccine can be given to people over 12 years of age. The corona vaccine of Zydus cadilla, named ZyCoV-D, is the world’s first indigenous vaccine based on DNA.

The vaccine has been developed in collaboration with the Department of Biotechnology, Government of India under Mission Covid Security. Corona vaccine ZyCoV-D from Indian company Zydus Cadila is special in many ways. It will take three doses, not one or two. Also it is not given by needle. As a result, the risk of side effects is also reduced.

The vaccine will be given without a needle
Zydus cadilla’s corona vaccine is the first plasmid DNA vaccine. In addition, it will be applied with the help of PharmaJet technology without the help of a needle, which reduces the risk of side effects. The drug is injected into the needle without a needle, then it is placed in the machine and placed on the hand. By clicking on the button on the machine, the vaccine reaches inside the body.

How effective is the vaccine?
In the interim results of the third phase trial conducted on more than 28,000 volunteers, the vaccine was found to be effective in 66-6% of RT-PCR positive cases. This was the largest test of the corona vaccine in India so far.

6th vaccine in the country
Ahmedabad-based company Zydus Cadila has developed the world’s first DNA-based covid vaccine. Tests have shown it to be up to 66% effective. Zidus Cadila is the 6th vaccine approved after Covishield, Kovacin, Sputnik V, Moderna and Johnson.

Serum Institute’s Covishield, Bharat Biotech’s Covacin and Russia’s Sputnik V vaccine are currently being used in India.

These 6 vaccines have been approved in India, find out who is most effective
Covishield – 90%
Covacin – 81%
Modern – 94.1%
Sputnik V – 91.6%
Johnson & Johnson – 85%
Zydus cadilla – 66%

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest Articles